CONNECTs
Our programmes
- See All
- Podcast
- Experts knowledge share
- E-learning
- Video
- Publication
- Other
Next-generation ARIs for nmCRPC: The role of the nurse
Jennifer Sutton provides an overview of safety considerations for next-generation androgen receptor inhibitors for non-metastatic castration-resistant prostate cancer and the role of the nurse.
Experts
Jennifer Sutton-
Downloadable
Resources -
3 MIN
-
Sep 2021
Downloadable 
3 MIN
Sep 2021 
Treatment sequencing for mCRPC: Providing crucial support to the patient
Brenda Martone provides a summary of how a GU nurse can provide crucial support to patients during treatment sequencing decisions for metastatic castration-resistant prostate cancer (mCRPC).
Experts
Brenda Martone-
Downloadable
Resources -
5 MIN
-
Sep 2021
GU NURSES CONNECT Update from ESMO 2021 and EONS14 (English)
GU NURSES CONNECT has summarised the oncology nursing highlights from ESMO 2021 and the European Oncology Nursing Society (EONS14).
Experts
Pablo Peinado-
Downloadable
Resources -
3 MIN
-
Sep 2021
mCRPC: Practical considerations when sequencing treatments in clinical practice
Joanne Chien provides an overview of practical considerations when sequencing treatments for mCRPC patients in clinical practice and how recent real-world data can help guide these decisions.
Experts
Joanne Chien-
Downloadable
Resources -
5 MIN
-
Sep 2021
The impact of COVID-19 on prostate cancer care
Janet Forgenie provides an overview of how COVID-19 has impacted prostate cancer care and side effect management.
Experts
Janet Forgenie-
Downloadable
Resources -
5 MIN
-
Sep 2021
GU NURSES CONNECT Update from ASCO 2020
GU NURSES CONNECT has summarised the highlights from ASCO 2020 for you.
Experts
Joanne Chien-
Downloadable
Resources -
5 MIN
-
Sep 2021
Key Publication Snapshot 5: TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
Experts
Dr Luca Toschi-
Downloadable
Resources -
5 MIN
-
Sep 2021
-
Downloadable
Resources -
5 MIN
-
Sep 2021
Key Publication Snapshot 3 – Characterisation of adverse events caused by TRK inhibitor therapy
Experts
Prof. Ezra Cohen-
Downloadable
Resources -
5 MIN
-
Sep 2021
Current opinions on how to identify and treat NTRK fusion positive cancer
Experts
Prof. David Hong, Prof. Ezra Cohen, Prof. Frédérique Penault-Llorca-
Downloadable
Resources -
5 MIN
-
Sep 2021
-
Downloadable
Resources -
5 MIN
-
Sep 2021
Learn about the patient journey through diagnosis and treatment of NTRK fusion positive cancer
Experts
Prof. Ulrik Lassen, Assoc. Prof. Caterina Marchiò-
5 MIN
-
Sep 2021
Key Publication Snapshot 2 – Identifying patients with NTRK fusion cancer
Experts
Prof. Fernando López-Ríos, MD, PhD-
Downloadable
Resources -
5 MIN
-
Sep 2021
NTRK gene fusions, TRK inhibitors and testing approaches BluePrint
Experts
Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, MD, PhD, Assoc. Prof. Gerald Prager-
Downloadable
Resources -
5 MIN
-
Sep 2021
Highlights BY NTRK CONNECT – Key NTRK fusion abstracts from ASCO and WCGIC 2021
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resources -
5 MIN
-
Sep 2021
NTRK CONNECT Update from ESMO 2019
Experts
Assoc. Prof. Caterina Marchiò-
Downloadable
Resources -
5 MIN
-
Sep 2021
Highlights BY NTRK CONNECT – Key NTRK fusion abstracts from USCAP, ELCC and AACR 2021
Experts
Dr Fernando Santini-
Downloadable
Resources -
5 MIN
-
Sep 2021
-
5 MIN
-
Sep 2021
An Experts’ Forum in Tokyo and Singapore on DDR and PARP inhibition
Experts
Prof. Keiichi Fujiwara, Prof. Simon Boulton, Dr Shinji Ohno, Dr Rebecca Dent, Prof. Charlie Gourley-
Downloadable
Resources -
60 MIN
-
Sep 2021
Other
The Role of DDR and PARP inhibition (PARPi) in Oncology – BluePrints
Experts
Dr Violeta Serra, Prof. Jonathan A. Ledermann, Prof. Eric Pujade-Lauraine, Prof. Simon Boulton, Dr Mark J. O'Connor, Prof. Charlie Gourley, Dr Judith Balmaña, Prof. Sibylle Loibl-
Downloadable
Resources -
MIN
-
Sep 2021
Video
Understand the MoA of PARP inhibitors and targeting DNA Damage Response (DDR)
Experts
Dr Robert L. Coleman, Prof. Simon Boulton-
Downloadable
Resources -
5 MIN
-
Sep 2021
Moving from PARP Inhibition to Targeting DNA Repair and DDR in Cancer Therapy
Experts
Dr Judith Balmaña, Dr Rebecca Dent, Prof. Simon Boulton, Prof. Sibylle Loibl, Prof. Eric Pujade-Lauraine, Prof. Charlie Gourley, Dr Violeta Serra, Prof. Jonathan A. Ledermann-
Downloadable
Resources -
10 MIN
-
Sep 2021
Interactive e-learning
The Role of PARP Inhibition in Prostate Cancer: e-Learning Now Available
Experts
Prof. Emmanuel S. Antonarakis, Dr Neal D. Shore, Dr Andrew J. Armstrong-
Downloadable
Resources -
60 MIN
-
Sep 2021
The Role of PARPi in Prostate Cancer: Experts Knowledge Share
Experts
Prof. Emmanuel S. Antonarakis, Dr Neal D. Shore, Dr Andrew J. Armstrong-
Downloadable
Resources -
5 MIN
-
Sep 2021
Interactive e-learning
The Role of PARP Inhibition in Clinical Practice
Experts
Prof. Jonathan A. Ledermann, Dr Rebecca Dent, Dr Robert L. Coleman, Prof. Eric Pujade-Lauraine-
60 MIN
-
Sep 2021
Maintenance therapy for metastatic urothelial cancer
GU CONNECT expert, Prof. Sandy Srinivas discusses maintenance therapy for metastatic urothelial cancer, and in particular the practice-changing clinical trial JAVELIN 100.
Experts
Prof. Sandy Srinivas-
Downloadable
Resources -
5 MIN
-
Sep 2021
Episode
1
of 3
Prostate Cancer Management Masterclass
Episode 1: An introduction
Experts
Dr Neal D. Shore, Assoc. Prof. Alicia Morgans, Assoc. Prof. Tanya Dorff, Prof. Evan Yu-
5 MIN
-
Sep 2021
Clinical review of nmCRPC: Key trials and endpoints
Prof. Steven Joniau provides an overview of nmCRPC and highlights of the SPARTAN, PROSPER and ARAMIS trials including the recent overall survival update and discusses the safety and quality of life data.
Experts
Prof. Steven Joniau-
Downloadable
Resources -
5 MIN
-
Sep 2021
The role and place of genetic testing in prostate cancer
Our GU CONNECT experts provide their thoughts and opinions on the challenging topic of the role and place of genetic testing in prostate cancer.
Experts
Dr Elena Castro, Dr Neal D. Shore, Dr Daniel Keizman, Prof. Gerhardt Attard-
Downloadable
Resources -
5 MIN
-
Sep 2021
Experts Knowledge Share: Managing nmCRPC and new imaging modalities
GU CONNECT has produced an interactive e-learning, slide set and video about current opinions on managing nmCRPC and the implications of new imaging modalities.
Experts
Prof. David Pfister, Assoc. Prof. Alicia Morgans-
Downloadable
Resources -
60 MIN
-
Sep 2021
Highlights of 2020 in prostate, urothelial and kidney cancer
Dr Ray Manneh Kopp takes a look at the highlights of 2020 from GU CONNECT.
Experts
Dr Ray Manneh Kopp-
Downloadable
Resources -
5 MIN
-
Sep 2021
-
Downloadable
Resources -
5 MIN
-
Oct 2021
-
Downloadable
Resources -
5 MIN
-
Oct 2021
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Optimal bone health management strategies in patients with prostate cancer
Experts
Dr Daniel Keizman-
Downloadable
Resources -
5 MIN
-
Oct 2021
Interactive e-learning
The SHARE Communication Framework for mCRPC: video, slides and e-learning
Experts
Assoc. Prof. Alicia Morgans, Prof. David Pfister, Assoc. Prof. Tanya DorffEndorsed by
-
Downloadable
Resources -
60 MIN
-
Oct 2021
Episode
2
of 3
Prostate Cancer Management Masterclass
Episode 2: mCSPC Plenary Session 1
Experts
Dr Neal D. Shore, Assoc. Prof. Alicia Morgans-
Downloadable
Resources -
35 MIN
-
Oct 2021
Episode
3
of 3
Prostate Cancer Management Masterclass
Episode 3: mCSPC Plenary Session 2
Experts
Prof. Evan Yu, Assoc. Prof. Tanya Dorff-
Downloadable
Resources -
60 MIN
-
Oct 2021
Episode
5
of 5
-
Downloadable
Resources -
5 MIN
-
Oct 2021
An update on the treatment of patients with mCRPC with RA-223 plus AAP
Experts
Prof. Tia Higano-
Downloadable
Resources -
5 MIN
-
Oct 2021
-
Downloadable
Resources -
5 MIN
-
Oct 2021
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Interactive e-learning
E-Learning: Treatment sequencing for mCRPC patients within the changing landscape of mHSPC
Experts
Assoc. Prof. Alicia Morgans, Prof. Gerhardt Attard-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
4
of 4
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Advances in metastatic hormone-sensitive prostate cancer
Experts
Assoc. Prof. Alicia Morgans-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
2
of 4
-
Downloadable
Resources -
5 MIN
-
Oct 2021
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
1
of 4
-
Downloadable
Resources -
5 MIN
-
Oct 2021
How to use combination, sequential and immuno-oncology therapies in mCRPC?
Experts
Prof. Evan Yu-
Downloadable
Resources -
5 MIN
-
Oct 2021
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
3
of 5
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Newly defined criteria for “platinum-ineligible” patients with metastatic urothelial cancer (mUC)
Experts
Assoc. Prof. Shilpa Gupta-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
3
of 3
GU CONNECT Update from ASCO GU 2020
Episode 3: Kidney Cancer
Experts
Assoc. Prof. Martin Pichler-
Downloadable
Resources -
5 MIN
-
Oct 2021
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
2
of 3
GU CONNECT Update from ASCO GU 2020
Episode 2: Urothelial Cancer
Experts
Assoc. Prof. Shilpa Gupta-
Downloadable
Resources -
5 MIN
-
Oct 2021
Treatment sequencing in metastatic renal cell carcinoma (mRCC)
Experts
Dr Roberto Iacovelli-
Downloadable
Resources -
5 MIN
-
Oct 2021
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
1
of 3
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
3
of 4
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
4
of 5
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
2
of 3
GU CONNECT Testicular Cancer Update from ESMO 2016
Episode 2
Experts
Assoc. Prof. Brian Costello-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
2
of 5
-
5 MIN
-
Oct 2021
Episode
1
of 3
GU CONNECT Prostate Cancer Update from ESMO 2016
Episode 1
Experts
Assoc. Prof. Tanya Dorff-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
1
of 5
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Management of Oligometastatic Prostate Cancer
GU CONNECT expert, Prof. Gert De Meerleer provides his perspective on the management of oligometastatic prostate cancer.
Experts
Prof. Gert De Meerleer-
Downloadable
Resources -
5 MIN
-
Oct 2021
mCSPC: Optimising patient selection and treatment
GU CONNECT expert, Dr Fabio Schutz provides his perspective on optimising patient selection and treatment options for metastatic castration-sensitive prostate cancer.
Experts
Dr Fabio Schutz-
Downloadable
Resources -
5 MIN
-
Oct 2021
An update on recent cutting-edge trials: Treatments now available for newly diagnosed mHSPC patients
Experts
Prof. Steven Joniau-
Downloadable
Resources -
5 MIN
-
Oct 2021
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
2
of 3
-
Downloadable
Resources -
5 MIN
-
Oct 2021
GU CONNECT Update from ESMO 2021
GU cancer update by Dr. Elena Castro, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
Experts
Dr Elena Castro-
Downloadable
Resources -
5 MIN
-
Oct 2021
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
3
of 3
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
3
of 3
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Episode
1
of 3
-
Downloadable
Resources -
5 MIN
-
Oct 2021
Optimising treatment sequence for mCRPC after intensified therapy in mCSPC
Dr. Neal Shore provides his perspective on treatment sequence for mCRPC after intensified therapy in mCSPC.
Experts
Dr Neal D. Shore-
Downloadable
Resources -
5 MIN
-
Oct 2021
Podcast
Radiopharmaceuticals in prostate cancer – radium-223 (Episode 1 of 2)
Episode 1 focuses on radium-223 and guest speaker Dr Neal Shore joins the discussion.
Experts
Dr Neal D. Shore, Assoc. Prof. Tanya Dorff, Dr Phillip Koo-
MIN
-
Oct 2021
Podcast
Radiopharmaceuticals in prostate cancer – PSMA Theranostics (Episode 2 of 2)
Episode 2 focuses on PSMA-targeted radiopharmaceuticals.
Experts
Dr Phillip Koo, Assoc. Prof. Tanya Dorff-
MIN
-
Oct 2021
GU NURSES CONNECT Update from ESMO 2021 and EONS14 (Español)
GU NURSES CONNECT ha resumido los aspectos más destacados de la enfermería oncológica de la ESMO 2021 y la Sociedad Europea de Enfermería Oncológica (EONS14).
Experts
Pablo Peinado-
Downloadable
Resources -
4 MIN
-
Oct 2021
Individualising treatment strategies for nmCRPC
Dr. Ray Manneh Kopp discusses treatment strategies for non-metastatic castration-resistant prostate cancer (nmCRPC) and how to individualise them to the patient.
Experts
Dr Ray Manneh Kopp-
Downloadable
Resources -
5 MIN
-
Oct 2021
PARP inhibition and DNA Damage Response (DDR)
This comprehensive resource looks at PARP inhibition and DDR as therapeutic targets across multiple tumour types
Experts
Prof. Simon Boulton, Dr Violeta Serra, Dr Judith Balmaña, Prof. Charlie Gourley-
30 MIN
-
Oct 2021
Video
Episode
1
of 3
Shared decision-making between nmCRPC patients and their healthcare team
Episode 1
Experts
Veerle Lamotte-
Downloadable
Resources -
4 MIN
-
Nov 2021
Video
Episode
2
of 3
Shared decision-making between nmCRPC patients and the healthcare team
Episode 2
Experts
Joanie Pfahl, Jennifer Sutton-
Downloadable
Resources -
4 MIN
-
Nov 2021
Video
Episode
3
of 3
Shared decision-making between nmCRPC patients and the healthcare team
Episode 3
Experts
Dr Jason Alcorn-
Downloadable
Resources -
2 MIN
-
Nov 2021
Podcast
The role of VEGFR-TKIs in the treatment of advanced RCC alone or in combination
Prof. Thomas Powles and GU CONNECT expert, Assoc. Prof. Georg Hutterer discuss the role of VEGFR-TKIs in the treatment of advanced renal cell carcinoma (RCC) alone or in combination with immunotherapy.
Experts
Assoc. Prof. Georg C Hutterer, Prof. Thomas Powles-
Downloadable
Resources -
MIN
-
Nov 2021
Integrating patient preference into treatment decisions for advanced prostate cancer
GU CONNECT expert, Dr. Alicia Morgans provides her perspective on how to integrate patient preference into treatment decisions for advanced prostate cancer.
Experts
Assoc. Prof. Alicia Morgans-
Downloadable
Resources -
5 MIN
-
Nov 2021
Highlights of 2021 in GU Oncology
Prof. David Pfister takes a look at the highlights of 2021 from GU CONNECT, in particular, the new trials and practice-changing developments in prostate, urothelial and kidney cancer.
Experts
Prof. David Pfister-
Downloadable
Resources -
5 MIN
-
Nov 2021
PARP inhibitors in Prostate Cancer
GU CONNECT has developed a comprehensive resource which is available on ESMO OncologyPRO, providing information on PARP inhibitors in prostate cancer
Experts
Dr Elena Castro, Dr Alexander Wyatt, Prof. Gerhardt Attard, Prof. Steven Joniau-
30 MIN
-
Dec 2021
Podcast
Episode
1
of 3
Genetic testing and PARP inhibitors in prostate cancer
Episode 1
Experts
Dr Alexander Wyatt, Joanne ChienEndorsed by
-
Downloadable
Resources -
MIN
-
Jan 2022
Podcast
Episode
2
of 3
The potential of PARP inhibitors in prostate cancer: What nurses need to know
Episode 2
Experts
Dr Elena Castro, Pablo PeinadoEndorsed by
-
Downloadable
Resources -
MIN
-
Jan 2022
Podcast
Episode
3
of 3
PARP inhibitors in prostate cancer: Management of adverse events and the importance of communication with patients
Episode 3
Experts
Assoc. Prof. Alicia Morgans, Dr Jason Alcorn-
Downloadable
Resources -
MIN
-
Jan 2022
Podcast
El potencial de los inhibidores de PARP en el cáncer de próstata: Lo que las enfermeras deben saber
En el segundo episodio de esta serie de podcasts, Pablo Peinado y la Dra. Elena Castro analizan los inhibidores de PARP, cómo funcionan, revisan datos clave de ensayos, cómo seleccionar PARPi y dónde encajan en la secuencia general de tratamiento.
Experts
Pablo Peinado, Dr Elena CastroEndorsed by
-
MIN
-
Jan 2022
Targeting Advanced Prostate Cancer with PARP inhibitors: Who, When and How?
On-demand educational resources (e-learning, video and slide set) are now available following a successful GU CONNECT Experts Knowledge Share event on the topic of targeting advanced prostate cancer with PARP inhibitors: Who, When and How?
Experts
Prof. Gerhardt Attard, Assoc. Prof. Tanya Dorff, Prof. Fred Saad-
Downloadable
Resources -
60 MIN
-
Feb 2022
PARP inhibitors in prostate cancer and the latest developments
Prof. Neeraj Agarwal takes a look at poly-ADP ribose polymerase inhibitors (PARPi's) in prostate cancer and in particular the latest clinical developments.
Experts
Prof. Neeraj Agarwal-
Downloadable
Resources -
5 MIN
-
Feb 2022
Podcast
Prostate Cancer Highlights from ASCO GU 2022
Experts
Assoc. Prof. Alicia Morgans, Dr Neal D. Shore-
Downloadable
Resources -
MIN
-
Mar 2022
Podcast
Shared decision-making in nmCRPC – Treatment considerations to maintain quality of life
Brenda Martone, Nurse Practitioner is joined by Assoc. Prof. Alicia Morgans from GU CONNECT to discuss shared decision-making in non-metastatic castration-resistant prostate cancer (nmCRPC) and the treatment considerations to maintain quality of life.
Experts
Brenda Martone, Assoc. Prof. Alicia Morgans-
Downloadable
Resources -
MIN
-
May 2022
Podcast
Podcast: Timing of ARSI and taxanes for mCSPC
In this podcast Assoc. Prof. Tanya Dorff and Dr Neal Shore focus on patients with metastatic castration-sensitive prostate cancer (mCSPC) and discuss when to use androgen receptor signalling inhibitors (ARSI) and taxanes for these patients.
Experts
Assoc. Prof. Tanya Dorff, Dr Neal Shore-
Downloadable
Resources -
MIN
-
May 2022
Conference update
Prostate Cancer Update from ASCO GU, ASCO and EAUN 2022
Prostate Cancer Update from ASCO GU, ASCO and EAUN 2022
Experts
Dr Jason Alcorn, Jennifer Sutton-
Downloadable
Resources -
25 MIN
-
Jul 2022
COR2ED at ESMO 2022
We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022. In 10 years, 500,000 healthcare professionals have trusted our educational programmes.
-
2 MIN
-
Sep 2022
Update From ESMO 2022 Presidential Sessions
COR2ED brings you an update on a selection of late-breaking abstracts presented in the Presidential Symposia at ESMO 2022.
Experts
Dr Thomas Winder, Dr Ray Manneh Kopp, Dr Alfredo Addeo-
10 MIN
-
Sep 2022
GU NURSES CONNECT Update from EONS15 at ESMO 2022 (English)
Pablo Peinado, Research Nurse Coordinator, reviews key abstracts from EONS15 at ESMO 2022.
Experts
Pablo Peinado-
Downloadable
Resources -
4 MIN
-
Sep 2022
Episode
1
of 2
GU CONNECT Prostate Cancer Update from ESMO 2022
Episode 1
Experts
Prof. Neeraj Agarwal, Dr Ray Manneh Kopp-
Downloadable
Resources -
8 MIN
-
Sep 2022
-
Downloadable
Resources -
5 MIN
-
Sep 2022
GU NURSES CONNECT Update from ESMO 2022 and EONS15 (Español)
GU NURSES CONNECT ha resumido los aspectos más destacados de la enfermería oncológica de la ESMO 2022 y la Sociedad Europea de Enfermería Oncológica (EONS15).
Experts
Pablo Peinado-
7 MIN
-
Oct 2022
Interactive e-learning
Experts Knowledge Share: Incorporating PARP inhibitors into prostate cancer clinical practice
On-demand e-learning, video replay and slide set now available
Experts
Prof. Fred Saad, Assoc. Prof. Tanya Dorff, Prof. Gerhardt Attard, Prof. Neeraj Agarwal-
Downloadable
Resources -
78 MIN
-
Nov 2022
Early Treatment Intensification for mCSPC: Optimising Patient Selection and Treatment
On-demand video and slides now available
Experts
Prof. Evan Yu-
Downloadable
Resources -
5 MIN
-
Dec 2022
Podcast
Targeted and Immunotherapies for Advanced Renal Cell Carcinoma
Educational podcast now available
Experts
Prof. Thomas Powles,-
20 MIN
-
Dec 2022
Micro learning
Module
1
of 2
PARP inhibitors in prostate cancer and the rationale behind combination treatment
Module 1 - PARP inhibitors in advanced prostate cancer
Experts
Assoc. Prof. Alicia Morgans, Dr Pasquale RescignoEndorsed by
-
Downloadable
Resources -
4 MIN
-
Jan 2023
Podcast
Episode
1
of 2
Systemic Therapies in Endometrial Carcinoma
The physicians' perspective
Experts
Dr Domenica Lorusso, Dr Mansoor Raza Mirza, Andreia Fernandes, Jo PearsonEndorsed by
-
Downloadable
Resources -
MIN
-
Feb 2023
Podcast
Episode
1
of 3
PARP inhibitors alone or in combination with novel hormonal agents in prostate cancer
Episode 1: Clinical implementation of PARPi monotherapy for prostate cancer patients – a US and EU perspective
Experts
Dr Neal Shore, Dr Elena CastroEndorsed by
-
Downloadable
Resources -
MIN
-
Feb 2023
Video
Episode
1
of 2
The Role of the Nurse in nmCRPC Patient Management
The role of the nurse in nmCRPC patient management
Experts
Pablo PeinadoEndorsed by
-
Downloadable
Resources -
5 MIN
-
Mar 2023
Podcast
Which mCSPC patients benefit from early treatment intensification?
A podcast from GU oncology experts
Experts
Assoc. Prof. Shilpa Gupta, Dr Fabio Schutz-
Downloadable
Resources -
MIN
-
Mar 2023
Conference update
Episode
1
of 6
Listen to Expert Insights on Late-Breaking Data from ASCO 2023
Episode 1: Non-Small-Cell Lung Cancer Update: ADAURA trial
Experts
Dr Mansoor Raza Mirza, Dr Paolo Tarantino, Prof. Alexey V Danilov, Prof. Mark Socinski, Prof. Evan Yu, Prof. Thomas Powles, Assoc. Prof. Gerald Prager-
2 MIN
-
Jun 2023
Podcast
Podcast: Treatment Intensification in mCSPC – The Nurse Perspective
Listen as GU oncology nurses share their views in this clinical update podcast
Experts
Brenda Martone, Jennifer SuttonEndorsed by
-
Downloadable
Resources -
MIN
-
Jun 2023
Conference update
Update from ASCO 2023: Late-Breaking RCC Data
Prof. Thomas Powles shares his perspective on key RCC data
Experts
Prof. Thomas Powles-
Downloadable
Resources -
3 MIN
-
Jun 2023
Video
Nursing Support for mCRPC Patients During Radiopharmaceutical Treatment
A clinical update for oncology nurses
Experts
Janet ForgenieEndorsed by
-
Downloadable
Resources -
3 MIN
-
Jul 2023
Video
Episode
1
of 2
Clinical implementation of testing and PARPi as monotherapy
Episode 1: Clinical implementation of testing and PARPi monotherapy
Experts
Dr Neal ShoreEndorsed by
-
Downloadable
Resources -
MIN
-
Jul 2023
Video
Episode
2
of 2
Clinical implementation of testing and PARPis in combination with NHAs
Episode 2: Clinical implementation of testing and PARP inhibitors in combination with NHAs
Experts
Dr Andrew J. ArmstrongEndorsed by
-
Downloadable
Resources -
MIN
-
Jul 2023
Interactive patient case
Optimising treatment for advanced RCC
Journey through an interactive patient case
Experts
Prof. Viktor Grünwald-
15 MIN
-
Oct 2023
Conference update
RCC Update from ESMO 2023
How will the latest data impact clinical practice?
Experts
Prof. Laurence Albiges-
Downloadable
Resources -
4 MIN
-
Oct 2023
Podcast
Episode
1
of 3
Prostate cancer: Pre-analytical phase challenges and biomarker testing
Moderated by the Oncology Brothers. Episode 1 of a 3-part video podcast series
Experts
Dr Alexander Wyatt, Dr Petros Grivas, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
MIN
-
Nov 2023
Precision oncology in practice – testing through to treatment in lung and prostate cancer
Molecular testing challenges and optimal biomarker testing approaches in lung and prostate cancer
Experts
Prof. Fernando López-Ríos, MD, PhD, Assoc. Prof. Alicia Morgans, Dr Herbert H. LoongEndorsed by
-
Downloadable
Resources -
MIN
-
May 2024
Other
Episode
1
of 2
Overcoming pre-analytical phase challenges in gastric, prostate and lung cancer
Medical experts make recommendations for best practice
Experts
Dr Alexander Wyatt, Prof. Frédéric BibeauEndorsed by
-
Downloadable
Resources -
5 MIN
-
Jun 2024
Interactive patient case
Advanced renal cell carcinoma: Managing a long-term durable response
Maximising outcomes for patients with advanced RCC
Experts
Prof. Michael StaehlerEndorsed by
-
MIN
-
Jun 2024
Other
Episode
2
of 2
Optimising samples for biomarker testing in lung, prostate and gastric cancer
Recommendations for best practice
Experts
Dr Alexander Wyatt, Prof. Frédéric BibeauEndorsed by
-
Downloadable
Resources -
5 MIN
-
Aug 2024
Conference update
ESMO 2024: New data on GI, lung, HCC, breast and GU cancers
Renowned medical experts share their insights into new data presented at ESMO 2024
-
Downloadable
Resources -
MIN
-
Sep 2024
Animated Video
Precision oncology in prostate and gastric cancer: tips for optimal genomic testing
From sample collection through to diagnostic modalities
Experts
Dr Alexander Wyatt, Prof. Frédéric BibeauEndorsed by
-
Downloadable
Resources -
MIN
-
Dec 2024
Video
Systemic treatment options for patients with non-clear cell renal cell carcinoma (nccRCC)
Managing patients with nccRCC: guidelines, recommendations, and best practice
Experts
Prof. Laurence AlbigesEndorsed by
-
Downloadable
Resources -
4 MIN
-
Dec 2024
Video
Recent advances in precision oncology and future implications
Two emerging and two established targets
Experts
Prof. David Hong-
Downloadable
Resources -
4 MIN
-
Dec 2024
Video
The patient perspective: Living with NSCLC driven by a rare alteration
What to know, what to expect, and where to find support
Experts
Marcia HornEndorsed by
-
8 MIN
-
Apr 2025